| Literature DB >> 18648655 |
Chizuko Maruyama1, Risa Araki, Mito Kawamura, Naoko Kondo, Mieko Kigawa, Yukari Kawai, Yoshikazu Takanami, Koichi Miyashita, Teruichi Shimomitsu.
Abstract
Effects of azuki bean juice supplementation, prescribed according to a Kanpo medicine regimen, on serum lipid concentrations were studied. Healthy young Japanese women were recruited and were randomly assigned to one of the three groups using a parallel-group design. Control (n = 10), azuki (n = 11) and Concentrated azuki (CA) (n = 12) juice groups consumed 150 g daily of the isocaloric assigned juice for one menstrual cycle with their usual diet. Triglyceride concentrations were decreased in the azuki juice group (p<0.05) and tended to be decreased in the CA juice group (p = 0.055). Triglyceride concentrations in the azuki and CA juice groups decreased by 0.170 mmol/liter (15.4%) and 0.159 mmol/liter (17.9%), respectively (p<0.05). The azuki and CA juice used in this study inhibited pancreatic lipase activity 29.2% and 56.9%, respectively, in vitro. Lipid peroxide changes, based on ANCOVA with the initial level and alpha-tocopherol changes as covariates, did not differ among the three groups. Serum low density lipoprotein-cholesterol and high density lipoprotein-cholesterol (HDL) cholesterol concentrations did not change. Thus, azuki bean juice intake, as a traditional Kampo prescription, might be beneficial for preventing hypertriglyceridemia.Entities:
Keywords: azuki; pancreatic lipase; polyphenol; triglyceride
Year: 2008 PMID: 18648655 PMCID: PMC2459248 DOI: 10.3164/jcbn.2008039
Source DB: PubMed Journal: J Clin Biochem Nutr ISSN: 0912-0009 Impact factor: 3.114
Baseline characteristics of subjects, changes in BMI and consumption state during the study
| Control juice | Azuki juice | Concentrated Azuki juice | ||
|---|---|---|---|---|
| ApoE phenotype | ||||
| 2/3 / 3/3 / 3/4 | 2/7/1 | 2/7/2 | 0/8/3 | |
| Age (year) | 21.2 ± 1.01 | 21.5 ± 0.5 | 21.3 ± 0.7 | |
| Height (cm) | 160.5 ± 3.6 | 158.7 ± 4.2 | 159.9 ± 4.9 | |
| Weight (kg) | baseline | 50.5 ± 2.6 | 50.3 ± 5.7 | 50.9 ± 5.4 |
| end | 51.1 ± 3.0* | 50.3 ± 5.8 | 50.8 ± 5.5 | |
| Consumption (days) | 25.1 ± 3.1 | 27.5 ± 2.7 | 26.8 ± 2.4 | |
| Compliance to cosume (%) | 92 ± 9 | 93 ± 7 | 97 ± 3 | |
| Volume consumed (ml/d) | 138 ± 13 | 140 ± 10 | 145 ± 4 |
Control juice group (n = 10), Azuki juice group (n = 11), Concentrated Azuki juice group (n = 12)
1 Values are means ± SD
*: Significant difference between baseline and final values at p<0.05.
Energy and nutrient intakes at baseline
| Energy (kcal/kg)1 | 30.7 ± 5.52 |
| (kJ/kg) | 128 ± 232 |
| Protein (g/kg) | 1.11 ± 0.23 |
| Fat, energy% | 30.4 ± 5.7 |
| Thiamin (mg/1000 kcal) | 0.50 ± 0.10 |
| Riboflavin (mg/1000 kcal) | 0.72 ± 0.21 |
| Niacin (mg/1000 kcal) | 7.8 ± 2.3 |
| Fiber (g/kg) | 0.23 ± 0.08 |
| Cholesterol (mg/kg) | 4.8 ± 2.2 |
| SFA (mg/kg) | 268 ± 119 |
| MUFA (mg/kg) | 276 ± 97 |
| n-6 PUFA (mg/kg) | 150 ± 52 |
| n-3 PUFA (mg/kg) | 37 ± 13 |
| Carotene (µg/kg) | 56 ± 33 |
| Ascorbic acid (mg/kg) | 2.1 ± 1.7 |
| α-Tocopherol (mg/kg) | 0.13 ± 0.11 |
n = 33
1 Values are expressed per standard body weight
2 Values are means ± SD
Serum lipid and biochemical parameter concentration changes with consumption of experimental juices
| Control juice | Azuki juice | Concentrated Azuki juice | |||
|---|---|---|---|---|---|
| Total cholesterol | (mmol/liter) | baseline | 4.47 ± 0.621 | 4.81 ± 0.39 | 4.75 ± 0.51 |
| end | 4.83 ± 0.67# | 4.71 ± 0.61 | 4.73 ± 0.66 | ||
| LDL-cholesterol | (mmol/liter) | baseline | 2.34 ± 0.52 | 2.59 ± 0.40 | 2.60 ± 0.50 |
| end | 2.49 ± 0.53 | 2.54 ± 0.63 | 2.56 ± 0.57 | ||
| HDL-cholesterol | (mmol/liter) | baseline | 1.89 ± 0.42 | 1.85 ± 0.32 | 1.82 ± 0.25 |
| end | 2.01 ± 0.50 | 1.83 ± 0.20 | 1.85 ± 0.24 | ||
| Triacylglycerol | (mmol/liter) | baseline | 0.73 ± 0.38 | 0.75 ± 0.35 | 0.64 ± 0.18 |
| end | 0.75 ± 0.31 | 0.61 ± 0.29# | 0.53 ± 0.17 | ||
| Aspartate aminotransferase | (µkat/liter) | baseline | 0.27 ± 0.05 | 0.31 ± 0.05 | 0.32 ± 0.06* |
| end | 0.30 ± 0.09 | 0.32 ± 0.07 | 0.32 ± 0.04 | ||
| Alanine aminotransferase | (µkat/liter) | baseline | 0.24 ± 0.09 | 0.24 ± 0.08 | 0.22 ± 0.07 |
| end | 0.27 ± 0.15 | 0.30 ± 0.12 | 0.19 ± 0.04 | ||
| Gamma- glutamyltransferase | (µkat/liter) | baseline | 0.28 ± 0.06 | 0.24 ± 0.07 | 0.25 ± 0.07 |
| end | 0.29 ± 0.10 | 0.23 ± 0.07 | 0.24 ± 0.05 | ||
| α-tocopherol | (µmol/liter) | baseline | 42.0 ± 8.4 | 34.6 ± 6.3* | 43.2 ± 3.9 |
| end | 47.1 ± 10.9# | 33.4 ± 6.0 | 42.7 ± 4.9 | ||
| Lipid peroxide | (nmol/ml) | baseline | 2.20 ± 0.16 | 2.40 ± 0.20 | 2.50 ± 0.24 |
| end | 2.30 ± 0.21 | 2.40 ± 0.22 | 2.50 ± 0.22 |
Control juice group (n = 10), Azuki juice group (n = 11), Concentrated Azuki juice group (n = 12)
1 Values are means ± SD
*: Significant difference vs Controls at p<0.05.
#: Significant change from baseline value at p<0.05.
Fig. 1Changes in serum triacylglycerol concentration in control (n = 10), azuki (n = 11) and concentrated azuki (n = 12) juice group during the study. Values are presented as means ± SE. # Significantly different from controls at p<0.05 based on ANCOVA adjusted for baseline values of triacyglycerol and aspartate aminotransferase.
Fig. 2Pancreatic lipase activity. The lipase activity at azuki juice free was expressed as 100%. The sample volume of 50 and 100 µl are equivalent to azuki and concentrated azuki bean juice, respectively.